Antidepressant-like activity of amisulpride in two animal models of depression

Journal of Psychopharmacology

Volumn 14, Issue 1, 2000, Pages 46-52

  Papp, Mariusz ^a   Wieronska, Joanna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Amisulpride; Antidepressant action; Chronic mild stress; Dopamine receptors; Forced swim test; Imipramine; Rat

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; IMIPRAMINE; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG POTENCY; FORCED SWIMMING TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

EID: 0034017322     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110001400106     Document Type: Article

References (56)

1. Alfredsson G, Sedvall G (1985) Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients: relationship to drug concentrations. Psychopharmacology 85: 8-13
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th edn. American Psychiatric Association: Washington, DC
3. Belmaker R H, Wald D (1977) Haloperidol in normals. Brit J Psychiatry 131: 222-223
4. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo M (1993) A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatrica Scand 88: 434-439
5. Boyer P, Lecrubier Y, Puech A J (1990) Treatment of positive and negative symptoms: pharmacologic approaches. In Andreasen A C (ed), Schizophrenia: positive and negative symptoms and syndromes. Modern problems in pharmacopsychiatry, vol. 24. Karger, Basel, Switzerland, pp. 152-174
6. Boyer P, Lecrubier Y, Puech A J, Laferriere N, Fleurot O (1992) Treatment of dysthymia with low-dose amisulpride versus amineptine. Clin Neuropharmacol 15 (Suppl. 1): 524B
7. Boyer P, Lecrubier Y, Puech A J, Dewailly J, Aubin F (1995) Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 166: 68-72
8. Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O (1999) Amisulpride versus amineptine and placebo for the treatment of dysthymia. Neuropsychobiology 39: 25-32
9. Bruynooghe F, Geerts S, Van Maele G, Vogtle Jungert U (1992) Behandlung reactiver Depressionen mit Sulpirid. Doppelblindstudie mit Sulprid und Amitriptylin im interindividuellen Vergleich. Fortschrit Med 110: 62-68
10. Chivers J K, Gommeren W, Leysen J E, Jenner P, Marsden C D (1988) Comparison of the in-vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors. J Pharm Pharmacol 40: 415-421
11. Delcker A, Schoon M L, Oczkowski B, Gaertner H J (1990 Amisulpride versus haloperidol in treatment of schizophrenic patients - results of a double-blind study. Pharmacopsychiatry 23: 125-130
12. Del Zompo M, Bocchetta A, Bernardi F, Burrai C, Corsini G U (1990) Clinical evidence for a role of dopaminergic system in depressive syndromes. In Gessa G L, Serra G (eds), Dopamine and mental depression. Pergamon Press, Oxford, pp. 177-184
13. Di Chiara G, Tanda G (1997) Blunting of dopamine transmission to palatable food: a biochemical marker of anhedonia in the CMS model. Psychopharmacology 134: 351-353
14. Ettenberg A (1989) Dopamine, neuroleptics and reinforced behavior. Pharmacol Biochem Behav 13: 105-111
15. Guyon A, Assouly Besse F, Biala G, Puech A J, Thiebot M H (1993) Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology 110: 460-466
16. Jenner P, Elliot P N C, Clow A, Reavill C, Marsden C D (1978) A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. J Pharm Pharmacol 30: 46-48
17. Lecrubier Y, Boyer P, Puech A J, Aubin F, Rein W (1992) Amisulpride versus imipramine and placebo in dysthymia. Clin Neuropharmacol 15 (Suppl. 1): 526B
18. Lecrubier Y, Boyer P, Turjanski S, Rein R (1997) Amisulpride versus imipramine and placebo in dysthymia and major depression. J Affect Dis 43: 95-103
19. Leon C A, Vigoya J, Conde S, Campo G, Castrillon E, Leon A (1994) Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia. Acta Psiquiatr Psicol Am Lat 40: 41-49
20. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8: 523-532
21. Maier W, Benkert O (1994) Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies. Psychopharmacology 115: 495-501
22. Matthews K, Forbes N, Reid A C (1995) Sucrose consumption as a hedonic measure following chronic unpredictable mild stress. Physiol Behav 57: 241-248
23. Moreau J-L, Jenck F, Martin J R, Mortas P, Haefely W E (1992) Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behaviour in rats. Eur Neuropsychopharmacol 2: 43-49
24. Moreau J-L, Jenck F, Martin J R, Mortas P, Haefely W E (1993) Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry 26: 30-33
25. Moreau J-L, Jenck F, Martin J R, Scherschlicht R (1994a) The chronic mild stress-induced anhedonia model of depression: REM sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 5 (Suppl. 1): 32
26. Moreau J-L, Borgulya J, Jenck F, Martin J R (1994b) Tolcapone: a potential new antidepressant detected in a novel animal model of depression. Behav Pharmacol 5: 344-351
27. Moreau J-L (1997) Validation d'un modele animale de l'anhedonie, symptome majeur de la depression. Encephale 23: 280-289
28. Muscat R, Sampson D, Willner P (1990) Dopaminergic mechanisms of imipramine action in an animal model of depression. Biol Psychiatry 28: 223-230
29. Muscat R, Papp M, Willner P (1992) Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology 109: 433-438
30. Nishiura M (1976) Clinic-pharmacologic studies of sulpiride. Current Ther Res 20: 164-172
31. Niskanen P, Tamminen T, Viukaru M (1975) Sulpiride vs. amitriptyline in the treatment of depression. Current Ther Res 17: 281-284
32. Paillere-Martinot M-L, Lecrubier Y, Martinot J-L, Aubin F (1994) Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. Am J Psychiatry 152: 130-133
33. Papp M, Willner P, Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104: 255-259
34. Papp M, Lappas S, Muscat R, Willner P (1992) Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J Psychopharmacol 6: 352-356
35. Papp M, Muscat R, Willner P (1993) Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress Psychopharmacology 110: 152-158
36. Papp M, Klimek V, Willner P (1994) Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115: 441-446
37. Papp M, Moryl E, Willner P (1996) Pharmacological validation of the chronic mild stress model of depression Eur J Pharmacol 296: 129-136
38. Perrault G, Depoortere R, Morel E, Sanger D J, Scatton B (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 280: 73-82
39. Phillips G, Willner P, Muscat R (1991) Reward-dependent suppression or facilitation of consummatory behaviour by raclopride. Psychopharmacology 105: 355-360
40. Porsolt R D, Anton G, Daniel M, Jalfre M (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391
41. Porsolt R D, Lenegre A, McArthur R A (1991) Pharmacological models of depression. In Olivier B, Mos J, Slangen J L (eds), Animal models in psychopharmacology, Birkhäuser Verlag, Basel, pp. 137-160
42. Randrup A, Munkvad I, Fog R, Gerlach J, Molander L, Kjellberg B, Scheel-Kruger J (1975) Mania, depression and brain dopamine. In Essman W B, Valzelli L (eds), Current developments in psychopharmacology, vol. 2. Spectrum Press, New York, pp. 206-248
43. Scatton B, Perrault G, Sanger D J, Shoemaker H, Carter C, Fage D, Gonon F, Chergui K, Cudennec A, Benavides J (1994) Pharmacological profile of amisulpride, an atypical neuroleptic which preferentially blocks presynaptic D2/D3 receptors. Neuropsychopharmacology 10 (Suppl. 1): 242S
44. Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280: 83-97
45. Siris S G (1991) Diagnosis of secondary depression in schizophrenia. Implications for DSM-IV. Schizophr Bull 17: 75-98
46. Sluzewska A, Nowakowska E (1994) The effects of carbamazepine, lithium and ketoconazole in chronic mild stress model of depression in rats. Behav Pharmacol 6 (Suppl. 1): 86
47. Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia and major depression in partial remission: a double-blind, comparative study. J Affect Disor 48: 47-56
48. Stamford J A, Muscat R, O'Connor J J, Patel J, Wieczorek W J, Kruk Z L, Willner P (1991). Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacology 105: 275-282
49. Standish-Barry H M A S, Bouras N, Bridges P K, Watson J P (1983) A randomized double-blind group comparative study of sulpiride and amitriptyline in affective disorder. Psychopharmacology 81: 258-260
50. Stunkard A J, Fernstrom M H, Price R A, Buss E, Frank E, Kupfer D J (1991) Weight change in depression: influence of 'disinhibition' is mediated by body mass and other variables. Psychiatr Res 38: 197-200
51. Willner P (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319-329
52. Willner P, Klimek V, Golembiowska K, Muscat R (1991) Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 19: 79-84
53. Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16: 525-534
54. Willner P, Moreau J-L, Nielsen C K, Papp M, Sluzewska A (1996) Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol Behav 60: 129-134
55. Winer B J (1971) Statistical principles in experimental design. McGraw Hill, London
56. Wise R A (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5: 39-87